Hopewell Therapeutics, Inc.

CIK 1836562 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Hopewell Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 17, 2025D0001836562-25-000003
May 17, 2024D/A0001836562-24-000001
Jun 2, 2023D0001836562-23-000001
Feb 2, 2022D0001836562-22-000001
Oct 8, 2021D0001836562-21-000002
Dec 21, 2020D0001836562-20-000001